Impact of Obesity on Cardiovascular Disease

被引:101
作者
Zalesin, Kerstyn C. [1 ]
Franklin, Barry A. [2 ]
Miller, Wendy M. [3 ]
Peterson, Eric D. [4 ]
McCullough, Peter A. [1 ]
机构
[1] William Beaumont Hosp, Dept Med, Div Nutr & Preventat Med, Royal Oak, MI 48073 USA
[2] William Beaumont Hosp, Cardiac Rehabil & Exercise Labs, Royal Oak, MI 48073 USA
[3] William Beaumont Hosp, Weight Control Ctr, Div Nutr & Preventat Med, Royal Oak, MI 48073 USA
[4] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA
关键词
D O I
10.1016/j.ecl.2008.06.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The epidemiology of cardiovacular disease risk factors is changing rapidly with the obesity pandemic. Obesity is independently associated with the risks for coronary heart disease, atrial fibrillation, and heart failure. Intra-abdominal obesity is also unique as a cardiovascular risk state in that it contributes to or directly causes most other modifiable risk factors, namely, hypertension, dysmetabolic syndrome, and type 2 diabetes mellitus. Obesity can also exacerbate cardiovascular disease through a variety of mechanisms including systemic inflammation, hypercoagulability, and activation of the sympathetic and reninangiotensin systems. Thus, weight reduction is a key strategy for simultaneous improvement in global cardiovascular risk, with anticipated improvements in survival and quality of life.
引用
收藏
页码:663 / +
页数:23
相关论文
共 122 条
  • [71] Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
  • [72] The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure
    Lissin, LW
    Gauri, AJ
    Froelicher, VF
    Ghayoumi, A
    Myers, J
    Giacommini, J
    [J]. JOURNAL OF CARDIAC FAILURE, 2002, 8 (04) : 206 - 215
  • [73] Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community
    Lopez-Jimenez, F
    Jacobsen, SJ
    Reeder, GS
    Weston, SA
    Meverden, RA
    Roger, VL
    [J]. CHEST, 2004, 125 (04) : 1205 - 1212
  • [74] Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity
    Malavazos, Alexis E.
    Ermetici, Federica
    Coman, Calin
    Corsi, Massimiliano M.
    Morricone, Lelio
    Ambrosi, Bruno
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 121 (01) : 132 - 134
  • [75] Obstructive sleep apnoea
    Malhotra, A
    White, DP
    [J]. LANCET, 2002, 360 (9328) : 237 - 245
  • [76] Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
    Mazzone, Theodore
    Meyer, Peter M.
    Feinstein, Steven B.
    Davidson, Michael H.
    Kondos, George T.
    D'Agostino, Ralph B., Sr.
    Perez, Alfonso
    Provost, Jean-Claude
    Haffner, Steven M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (21): : 2572 - 2581
  • [77] Lipoprotein-associated phospholipase A2
    McConnell, Joseph P.
    Hoefner, Daniel M.
    [J]. CLINICS IN LABORATORY MEDICINE, 2006, 26 (03) : 679 - +
  • [78] Adiposity of the heart*, revisited
    McGavock, JM
    Victor, RG
    Unger, RH
    Szczepaniak, LS
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (07) : 517 - 524
  • [79] CARDIOPATHY OF OBESITY - A NOT-SO-VICTORIAN DISEASE
    MESSERLI, FH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (06) : 378 - 380
  • [80] Miller Wendy M, 2005, Expert Rev Cardiovasc Ther, V3, P743, DOI 10.1586/14779072.3.4.743